Clinical outcomes and immune responses in a phase I/II study of personalized, neoantigen-directed immunotherapy in patients with advanced MSS-CRC, GEA and NSCLC Meeting Abstract
| Authors: | Catenacci, D. V.; Liao, C. Y.; Maron, S.; Solomon, B. J.; Mahipal, A.; Johnson, M. L.; Carbone, D.; Henick, B. S.; Johnson, B.; Roychowdhury, S.; Mody, K.; Ahn, D. H.; Bournazou, E.; Schenk, D.; Kounlavouth, S.; Kraemer, L.; Talbot, G.; Rousseau, R.; Ferguson, A. R.; Spira, A. |
| Abstract Title: | Clinical outcomes and immune responses in a phase I/II study of personalized, neoantigen-directed immunotherapy in patients with advanced MSS-CRC, GEA and NSCLC |
| Meeting Title: | ESMO Congress 2021 |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2021 Sep 16-21 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-09-01 |
| Start Page: | S830 |
| End Page: | S831 |
| Language: | English |
| ACCESSION: | WOS:000700527701423 |
| DOI: | 10.1016/j.annonc.2021.08.1345 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract #960MO -- Source: Wos |
